Skip to main content

Site notifications

(Approval lapsed) Desmopressin Acetate Nasal Solution (Nasal Spray) 10mcg/0.1mL per spray 5mL bottle (Zydus Pharmaceuticals)

Section 19A approved medicine
(Approval lapsed) Desmopressin Acetate Nasal Solution (Nasal Spray) 10mcg/0.1mL per spray 5mL bottle (Zydus Pharmaceuticals)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
MINIRIN desmopressin acetate 10 microgram/ actuation nasal spray - ARTG 59320
Indication(s)
  • Diabetes Insipidus - The treatment of ADH-sensitive cranial diabetes insipidus, including treatment of post-hypophysectomy polydipsia and polyuria.
  • Nocturnal Enuresis - The symptomatic treatment of primary nocturnal enuresis in patients who have normal ability to concentrate urine. Desmopressin Acetate Nasal Solution (Nasal Spray) 10mcg/0.1mL per spray (Zydus Pharmaceuticals) should be used only in patients who are refractory to the enuresis alarm or in patients in whom enuresis alarm is contraindicated or inappropriate, and where the oral administration of desmopressin is not feasible.
  • Renal Concentrating Capacity - By intranasal administration to adults and children as a diagnostic test to establish renal concentrating capacity.
Published

Help us improve the Therapeutic Goods Administration site